Molecular epidemiology of HIV-1 subtypes in southern China

J Acquir Immune Defic Syndr. 2005 Mar 1;38(3):356-62.

Abstract

The driving forces of the HIV-1 epidemic in Guangxi, China were assessed by investigating virologic and epidemiologic data from a cohort of longitudinally followed injection drug users (IDUs) in Binyang and Pingxiang, major urban areas along 2 separate drug routes in the province. Sera and interview data were obtained in September and October of 2000. Sequence analysis of HIV-1 was performed on the gag-pol region (HXB2 nt 1850-3005) and C2 to V4 env (HXB2 nt 6704-7626). Sequence data demonstrated that 88% of the infections in Pingxiang were CRF01_AE, whereas 96% in Bin-yang were CRF08_BC. Three recently infected subjects in Pingxiang were infected with CRF08_BC, and 1 chronically infected subject had evidence of a recombinant virus. Intersubject distances were statistically greater for CRF01_AE-infected subjects than CRF08_BC-infected subjects for all regions except V4. The epidemic in Binyang is similar to previously described IDU-based epidemics, with a strong founder effect with little variation in V3. The epidemic in Pingxiang may have had multiple introductions of the CRF01_AE epidemic into the city and greater spread through sexual transmission, resulting in greater variation in V3 than typically seen in purely parenterally based epidemics.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Amino Acid Sequence
  • China / epidemiology
  • DNA, Complementary
  • DNA, Viral / chemistry
  • DNA, Viral / isolation & purification
  • Female
  • Fusion Proteins, gag-pol / genetics
  • Gene Products, env / chemistry
  • Genes, env
  • Genes, gag
  • Genes, pol
  • HIV Infections / epidemiology*
  • HIV Infections / virology*
  • HIV Protease / chemistry
  • HIV Protease / genetics
  • HIV Reverse Transcriptase / chemistry
  • HIV Reverse Transcriptase / genetics
  • HIV-1 / classification*
  • HIV-1 / genetics
  • HIV-1 / isolation & purification*
  • Humans
  • Male
  • Middle Aged
  • Molecular Epidemiology
  • Molecular Sequence Data
  • Phylogeny
  • Sequence Alignment
  • Sequence Analysis, DNA
  • Substance Abuse, Intravenous / complications
  • Urban Population

Substances

  • DNA, Complementary
  • DNA, Viral
  • Fusion Proteins, gag-pol
  • Gene Products, env
  • HIV Reverse Transcriptase
  • HIV Protease

Associated data

  • GENBANK/AY635691
  • GENBANK/AY635692
  • GENBANK/AY635693
  • GENBANK/AY635694
  • GENBANK/AY635695
  • GENBANK/AY635696
  • GENBANK/AY635697
  • GENBANK/AY635698
  • GENBANK/AY635699
  • GENBANK/AY635700
  • GENBANK/AY635701
  • GENBANK/AY635702
  • GENBANK/AY635703
  • GENBANK/AY635704
  • GENBANK/AY635705
  • GENBANK/AY635706
  • GENBANK/AY635707
  • GENBANK/AY635708
  • GENBANK/AY635709
  • GENBANK/AY635710
  • GENBANK/AY635711
  • GENBANK/AY635712
  • GENBANK/AY635713
  • GENBANK/AY635714
  • GENBANK/AY635715
  • GENBANK/AY635716
  • GENBANK/AY635717
  • GENBANK/AY635718
  • GENBANK/AY635719
  • GENBANK/AY635720
  • GENBANK/AY635721
  • GENBANK/AY635722
  • GENBANK/AY635723
  • GENBANK/AY635724
  • GENBANK/AY635725
  • GENBANK/AY635726
  • GENBANK/AY635727
  • GENBANK/AY635728
  • GENBANK/AY635729
  • GENBANK/AY635730
  • GENBANK/AY635731
  • GENBANK/AY635732
  • GENBANK/AY635733
  • GENBANK/AY635734
  • GENBANK/AY635735
  • GENBANK/AY635736
  • GENBANK/AY635737
  • GENBANK/AY635738
  • GENBANK/AY635739
  • GENBANK/AY635740
  • GENBANK/AY635741
  • GENBANK/AY635742
  • GENBANK/AY635743
  • GENBANK/AY635744
  • GENBANK/AY635745
  • GENBANK/AY635746
  • GENBANK/AY635747
  • GENBANK/AY635748
  • GENBANK/AY635749
  • GENBANK/AY635750
  • GENBANK/AY635751
  • GENBANK/AY635752
  • GENBANK/AY635753
  • GENBANK/AY635754
  • GENBANK/AY635755
  • GENBANK/AY635756
  • GENBANK/AY635757
  • GENBANK/AY635758
  • GENBANK/AY635759
  • GENBANK/AY635760
  • GENBANK/AY635761
  • GENBANK/AY635762